Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?
- PMID: 28265568
- PMCID: PMC5318620
- DOI: 10.1155/2017/1438027
Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?
Abstract
Purpose. To identify pathological characteristics of prostate cancer according to patient age at diagnosis. Methods. A retrospective review of 2,929 men diagnosed with prostate cancer was performed. Pathological characteristics were compared across age groups: ≤55, 56-75, and >75 years. Results. The study cohort included 133 patients (4.5%), 2,033 patients (69.5%), and 763 patients (26.0%) in the three age groups, respectively. The median pathological Gleason sums in the three age groups were 8, 7, and 8, respectively. The Gleason sum, primary Gleason score, and second primary Gleason score were significantly different among the three age groups (Z = 12.975, p = 0.002; Z = 9.264, p = 0.010; Z = 6.692, p = 0.035, resp.). The percentages of Gleason pattern 5 tumors for the three age groups were 44.4%, 32.3%, and 36.8%, respectively; they were significantly different (χ2 = 11.641, p = 0.003). The percentages of tumors with Gleason score grade groups 3-5 for the three age groups were 66.9%, 60.5%, and 66.3%, respectively; they were significantly different (χ2 = 9.401, p = 0.009). Conclusions. The present study indicated that men aged ≤55 years or >75 years show higher levels of clinically significant prostate cancer compared to patients between the ages of 55 and 75 years. Younger and more elderly male patients are more likely to have a more aggressive disease.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4. BJU Int. 2013. PMID: 22487441
-
Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.J Urol. 2002 Aug;168(2):525-9. J Urol. 2002. PMID: 12131302
-
[Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer].Zhonghua Wai Ke Za Zhi. 2013 Dec;51(12):1089-93. Zhonghua Wai Ke Za Zhi. 2013. PMID: 24499718 Chinese.
-
Is transperineal prostate biopsy more accurate than transrectal biopsy in determining final Gleason score and clinical risk category? A comparative analysis.BJU Int. 2015 Oct;116 Suppl 3:26-30. doi: 10.1111/bju.13165. Epub 2015 Aug 11. BJU Int. 2015. PMID: 26260531
-
Prostate biopsy: who, how and when. An update.Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Can J Urol. 2005. PMID: 15780165 Review.
Cited by
-
Predictors of well-being and quality of life in men who underwent radical prostatectomy: longitudinal study1.Rev Lat Am Enfermagem. 2018 Sep 3;26:e3031. doi: 10.1590/1518-8345.2601.3031. Rev Lat Am Enfermagem. 2018. PMID: 30183870 Free PMC article.
-
Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen.Biosensors (Basel). 2023 Mar 2;13(3):334. doi: 10.3390/bios13030334. Biosensors (Basel). 2023. PMID: 36979546 Free PMC article.
-
Is age an independent risk factor for perioperative mortality and morbidity after radical prostatectomy? Analysis of the American college of surgeons national surgical quality improvement program database.Arab J Urol. 2020 Feb 11;18(2):72-77. doi: 10.1080/2090598X.2020.1721165. Arab J Urol. 2020. PMID: 33029410 Free PMC article.
-
TGM4: an immunogenic prostate-restricted antigen.J Immunother Cancer. 2021 Jun;9(6):e001649. doi: 10.1136/jitc-2020-001649. J Immunother Cancer. 2021. PMID: 34193566 Free PMC article.
-
Impact of Body Mass Index on Oncological Outcomes of Prostate Cancer Patients after Radical Prostatectomy.Sci Rep. 2018 Aug 10;8(1):11962. doi: 10.1038/s41598-018-30473-y. Sci Rep. 2018. PMID: 30097640 Free PMC article.
References
-
- Mohler J. L., Kantoff P. W., Armstrong A. J., et al. Prostate cancer, version 2.2014. Journal of the National Comprehensive Cancer Network. 2014;12(5):686–718. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical